Genome mapping is crucial for identifying the relative positions of genes or loci on a chromosome. Two primary approaches are utilized: genetic mapping and physical mapping.
| Mapping Category | Key Features & Markers Used | Methodology & Resolution | Major Limitations |
|---|---|---|---|
| Genetic Mapping | Phenotypic traits, recombination frequency, centimorgan (cM). | Measures crossing-over frequency between loci; $1\text{ cM} = 1\text{%}$ recombination frequency. Low resolution. | Sparsely populated due to limited number of well-known phenotypic genetic loci. |
| Physical Mapping | RFLP, SSLP, STS. | Identifies physical coordinates/base distances on chromosomes using restriction digestion, PCR, and gel electrophoresis. High resolution. | Requires physical DNA clones and sequence information; complex assembly for large genomes. |
DNA sequencing technology has evolved through three distinct generations, dramatically reducing costs and increasing throughput.
| Generation Phase | Platform Names / Examples | Workflow Steps & Mechanics | Read Length & Cost/Speed Trade-offs |
|---|---|---|---|
| First Generation | Sanger Sequencing / Capillary Electrophoresis | Chain termination using fluorescently tagged ddNTPs; capillary gel electrophoresis separates fragments by size; fluorescence detector reads peaks. | 800–1000 bp reads; highly accurate but slow, labor-intensive, and prohibitively expensive for whole genomes. |
| Second Generation (Next-Gen) | Illumina Sequencing | Clonal amplification via Bridge PCR on a flow cell; sequencing-by-synthesis using reversible terminator fluorescent dNTPs; parallel imaging of millions of clusters. | Short reads (75–300 bp); extremely high throughput, massively parallel, and dramatically lower cost per base. |
| Third Generation | Nanopore Sequencing (Oxford Nanopore) | Single-stranded DNA is threaded through a protein pore (porin) by a DNA helicase; measures characteristic disruptions in ionic current across a synthetic membrane. | Ultra-long reads (up to 1 Mb or more); real-time data output, rapid sample prep, portable, but slightly higher raw error rates. |
Genome engineering involves targeted modifications to introduce, remove, or edit specific genetic sequences within an organism.
Deals with the physical nature of the whole genome, including chromosome organization, nucleosome status, and the 3D structures of all proteins encoded by the genome.
Aims to understand how the physiological and pathological information encoded in the genome is executed, utilizing tools like RNASeq, ChipSeq, and Metagenomics.
Compares genes and genomes across different species or individuals to identify evolutionary relationships, core conserved genes, and species-specific unique traits.
Protein engineering uses recombinant DNA technology to modify codon sequences, producing proteins with enhanced stability, activity, or novel therapeutic properties.
Wild-type subtilisin contains Met 222 in its active site which is easily oxidised in the presence of bleach, leading to a drastic reduction in its proteolytic cleansing action in detergents.
Engineering Methodology & Mechanism: Use site-directed mutagenesis to replace the codon for Met 222 with a codon for Ala. This point mutation preserves the catalytic triad (Ser 221, His 64, and Asp 32) while rendering the engineered enzyme highly stable and active even in bleach-containing detergents.
Wild-type recombinant proteins lack specific high-affinity handles, making their purification from complex cellular lysates highly tedious and low-yield.
Engineering Methodology & Mechanism: Fuse DNA encoding a 6-His-Tag (six consecutive histidine residues) to the gene of interest. The resulting chimeric protein binds with high affinity to divalent metal ions (such as Nickel, Zinc, or Cobalt) immobilized on agarose columns at mildly alkaline pH, allowing easy elution with imidazole or elution buffer.
In vivo tracking of protein localization and dynamics within living cells is impossible without destructive chemical staining or cell lysis.
Engineering Methodology & Mechanism: Fuse the gene encoding Green Fluorescent Protein (GFP) from the jellyfish Aequorea victoria to the target gene. The resulting chimeric fusion protein retains its native localization and emits green fluorescence under UV light, enabling real-time tracking via confocal microscopy.
Systemic administration of wild-type cellular toxins (e.g., Pseudomonas exotoxin) causes lethal non-specific toxicity, while wild-type antibodies lack sufficient cell-killing potency.
Engineering Methodology & Mechanism: Engineer a single-chain variable fragment (scFv) containing the variable heavy ($V_H$) and light ($V_L$) domains of a tumor-specific antibody linked by a flexible peptide. Fuse this scFv DNA sequence to a truncated toxin gene (e.g., Pseudomonas exotoxin A or Diphtheria toxin). The chimeric protein selectively binds cancer cell surface antigens, undergoes endocytosis, and releases the toxin to kill the target cell.
Mouse monoclonal antibodies produced via hybridoma technology trigger a severe anti-mouse immune response (HAMA) when administered therapeutically to humans, neutralizing their efficacy.
Engineering Methodology & Mechanism: Identify the antigen-binding complementarity-determining regions (CDRs) of the mouse antibody. Transfer these specific DNA sequences to the equivalent positions in a human antibody framework gene. The resulting humanised monoclonal antibody retains high antigen affinity while being recognized as "self" by the human immune system.